Search
Value Research Stocks

New stock recommendations released!

Reliance Pharma Fund Unrated

Value Research
0.97%
Change from previous, NAV as on Nov 17, 2017
Category: Equity: Pharma
Assets: R 1,687 crore (As on Oct 31, 2017)
Expense: 2.13% (As on Oct 31, 2017)
SUBSCRIBE TO THE VALUE RESEARCH FUNDLINE NEWSLETTER
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers
+ Sailesh Raj Bhan since Mar 2005
comments powered by Disqus